Ad
related to: jazz pharmaceuticals
Search results
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) Q3 2022 Earnings Call Transcript November 9, 2022 Jazz...
Zacks Industry Outlook Highlights Jazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie...
Zacks via Yahoo Finance· 2 years agoJazz Pharmaceuticals, Catalyst Pharmaceuticals, Aerie Pharmaceuticals, Larimar Therapeutics and...
Jazz Pharmaceuticals PLC (JAZZ) Reports Strong Revenue Growth and Robust Pipeline Progress
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenues: $3.8 billion in 2023, with a 27% year-over-year increase from key growth drivers....
Are Options Traders Betting on a Big Move in Jazz Pharmaceuticals (JAZZ) Stock?
Zacks via Yahoo Finance· 1 year agoInvestors in Jazz Pharmaceuticals plc JAZZ need to pay close attention to the stock based on moves...
Shareholders in Jazz Pharmaceuticals (NASDAQ:JAZZ) have lost 14%, as stock drops 3.3% this past week
Simply Wall St. via Yahoo Finance· 2 years agoFor many, the main point of investing is to generate higher returns than the overall market. But in...
Why Earnings Season Could Be Great for Jazz Pharmaceuticals (JAZZ)
Zacks via Yahoo Finance· 1 year agoJazz Pharmaceuticals (JAZZ) is seeing favorable earnings estimate revision activity and has a...
Jazz (JAZZ) Starts Study on Epidiolex for a Fourth Indication
Zacks via Yahoo Finance· 2 years agoJazz Pharmaceuticals (JAZZ) initiates a two-part pivotal late-stage study evaluating its epilepsy...
My Top Cannabis Stock to Buy in 2023 and Hold For 10 Years
Motley Fool· 1 year agoA few years ago, the cannabis industry attracted much interest from investors following significant...
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 2 years agoJazz (JAZZ) possesses the right combination of the two key ingredients for a likely earnings beat in...
Jazz (JAZZ) Lags on Q1 Earnings & Sales, Reaffirms '23 View
Zacks via Yahoo Finance· 1 year agoJazz Pharmaceuticals JAZZ reported adjusted earnings of $3.95 per share in first-quarter 2023,...